These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 2448760

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F, Chalansonnet M, Carabin N, Micillino JC.
    Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
    [Abstract] [Full Text] [Related]

  • 23. Pharmacological effects of serotonin reuptake inhibitors.
    Leonard BE.
    J Clin Psychiatry; 1988 Aug; 49 Suppl():12-7. PubMed ID: 3045106
    [Abstract] [Full Text] [Related]

  • 24. N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-nitrophenyl) cyclohexanecarboxamide: a novel pre- and postsynaptic 5-hydroxytryptamine(1A) receptor antagonist active on the lower urinary tract.
    Leonardi A, Guarneri L, Poggesi E, Angelico P, Velasco C, Cilia A, Testa R.
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1027-37. PubMed ID: 11714892
    [Abstract] [Full Text] [Related]

  • 25. Bupropion: a review of its mechanism of antidepressant activity.
    Ascher JA, Cole JO, Colin JN, Feighner JP, Ferris RM, Fibiger HC, Golden RN, Martin P, Potter WZ, Richelson E.
    J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
    [Abstract] [Full Text] [Related]

  • 26. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
    Clineschmidt BV, Reiss DR, Pettibone DJ, Robinson JL.
    J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
    [Abstract] [Full Text] [Related]

  • 27. Antidepressant profile of 9-methyl-2[-3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro-beta- carbolin-1-one (B-193).
    Wiczyńska B, Antkiewicz-Michaluk L, Pilc A, Chojnacka-Wójcik E, Przegaliński E.
    Pol J Pharmacol Pharm; 1989 Dec; 41(4):331-44. PubMed ID: 2636891
    [Abstract] [Full Text] [Related]

  • 28. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL.
    J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
    [Abstract] [Full Text] [Related]

  • 29. The effects of co-administration of 3,4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats.
    Stanley N, Salem A, Irvine RJ.
    Neuroscience; 2007 Apr 25; 146(1):321-9. PubMed ID: 17306465
    [Abstract] [Full Text] [Related]

  • 30. The effect of repeated treatment with oxaprotiline enantiomers on central 5-HT receptor subpopulations.
    Dereń-Wesołek A, Maj J.
    Pol J Pharmacol; 1993 Apr 25; 45(2):133-50. PubMed ID: 8401766
    [Abstract] [Full Text] [Related]

  • 31. The effect of maprotiline on brain serotonin metabolism in rats.
    Benesová O, Benes V.
    Act Nerv Super (Praha); 1974 Aug 25; 16(3):190-1. PubMed ID: 4419548
    [No Abstract] [Full Text] [Related]

  • 32. The effect of etoperidone, a new potential antidepressant drug, on the central serotonin system.
    Przegaliński E, Lewandowska A.
    J Neural Transm; 1979 Aug 25; 46(4):303-12. PubMed ID: 529000
    [Abstract] [Full Text] [Related]

  • 33. Effect of 1-(m-trifluoromethylphenyl)-piperazine on 3H-serotonin binding to membranes from rat brain in vitro and on serotonin turnover in rat brain in vivo.
    Fuller RW, Snoddy HD, Mason NR, Molloy BR.
    Eur J Pharmacol; 1978 Nov 01; 52(1):11-6. PubMed ID: 720384
    [Abstract] [Full Text] [Related]

  • 34. Hydroxytryptamine turnover decreased by the antidepressant drug chlorimipramine.
    Meek J, Werdinus B.
    J Pharm Pharmacol; 1970 Feb 01; 22(2):141-3. PubMed ID: 4392254
    [No Abstract] [Full Text] [Related]

  • 35. Effects of trazodone on serotonin in the brain and platelets of the rat.
    Garattini S, De Gaetano G, Samanin R, Bernasconi S, Roncaglioni MC.
    Biochem Pharmacol; 1976 Jan 01; 25(1):13-6. PubMed ID: 1252251
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Endocoids in depression: do antidepressants alter endocoids that affect the serotonergic system?
    Leonard BE.
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Jul 01; 17(4):505-14. PubMed ID: 8395698
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. An In Vitro Study of the Neurotoxic Effects of N-Benzylpiperazine: A Designer Drug of Abuse.
    Persona K, Polus A, Góralska J, Gruca A, Dembińska-Kieć A, Piekoszewski W.
    Neurotox Res; 2016 May 01; 29(4):558-68. PubMed ID: 26861955
    [Abstract] [Full Text] [Related]

  • 40. Acute effects of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) using functional magnetic resonance imaging (fMRI) and the Stroop task--a pilot study.
    Curley LE, Kydd RR, Robertson MC, Pillai A, McNair N, Lee H, Kirk IJ, Russell BR.
    Psychopharmacology (Berl); 2015 Aug 01; 232(16):2969-80. PubMed ID: 25893641
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.